Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer.

Köster W, Heider A, Niederle N, Wilke H, Stamatis G, Fischer JR, Koch JA, Stahl M.

J Thorac Oncol. 2007 Apr;2(4):312-6.

2.

Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.

Yoshimura N, Kudoh S, Kimura T, Mitsuoka S, Kyoh S, Tochino Y, Asai K, Kodama T, Ichimaru Y, Yana T, Hirata K.

J Thorac Oncol. 2009 Mar;4(3):371-5. doi: 10.1097/JTO.0b013e31819846e4.

3.

A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer.

Chiappori AA, Ellis PM, Hamm JT, Bitran JD, Eiseman I, Lovalvo J, Burnett D, Olson S, Lenehan P, Zinner RG.

J Thorac Oncol. 2006 Nov;1(9):1010-9.

4.

Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.

Hesketh PJ, McCoy J, Dunphy FR 2nd, Bearden JD 3rd, Weiss GR, Giguere JK, Atkins JN, Dakhil SR, Kelly K, Crowley JJ, Gandara DR.

J Thorac Oncol. 2006 Nov;1(9):991-5.

5.

Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer.

Ishimoto O, Sugawara S, Inoue A, Ishida T, Munakata M, Koinumaru S, Hasegawa Y, Suzuki T, Miki H, Saijo Y, Nukiwa T.

J Thorac Oncol. 2006 Nov;1(9):979-83.

6.

A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.

Feigenberg SJ, Hanlon AL, Langer C, Goldberg M, Nicolaou N, Millenson M, Coia LR, Lanciano R, Movsas B.

J Thorac Oncol. 2007 Apr;2(4):287-92.

7.

A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.

Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA Jr.

Clin Cancer Res. 1997 Jul;3(7):1117-23.

8.
9.

Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.

Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.

Cancer. 1996 Oct 15;78(8):1701-7.

10.

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

Gajra A, Mehdi SA, Kirshner J, Newman N, Graziano SL.

Lung Cancer. 2001 May;32(2):189-96.

PMID:
11325490
11.

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.

Thomas P, Robinet G, Ferri-Dessens RM, Léna H, Gouva S, Vernejoux JM, Kleisbauer JP.

Lung Cancer. 2002 May;36(2):191-8.

PMID:
11955654
12.

A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.

Gillenwater HH, McCune JS, Lindley C, Faucette S, Shord S, Donahue A, Socinski MA, Stewart CF, Zamboni WC, Kirstein MN, Moore D.

Cancer Invest. 2005;23(6):511-9.

PMID:
16203659
13.

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, Scagliotti G, Rosell R, Oliff I, Reeves JA, Wolf MK, Krebs AD, Averbuch SD, Ochs JS, Grous J, Fandi A, Johnson DH.

J Clin Oncol. 2004 Mar 1;22(5):785-94.

PMID:
14990633
14.

A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report.

Pillot GA, Read WL, Hennenfent KL, Marsh S, Gao F, Viswanathan A, Cummings K, McLeod HL, Govindan R.

J Thorac Oncol. 2006 Nov;1(9):972-8.

15.

Phase II study of docetaxel and carboplatin as second-line treatment in NSCLC.

Wachters FM, van Putten JW, Boezen HM, Groen HJ.

Lung Cancer. 2004 Aug;45(2):255-62.

PMID:
15246198
16.

Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Spigel DR, Hainsworth JD, Simons L, Meng C, Burris HA 3rd, Yardley DA, Grapski R, Schreeder M, Mallidi PV, Greco FA; Minnie Pearl Cancer Research Network..

J Thorac Oncol. 2007 Sep;2(9):854-61.

17.

A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer.

Inoue A, Yamazaki K, Maemondo M, Suzuki T, Kimura Y, Kanbe M, Isobe H, Nishimura M, Saijo Y, Nukiwa T.

J Thorac Oncol. 2006 Jul;1(6):551-5.

18.

A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancer.

Spigel DR, Hainsworth JD, Gandhi JG, Gian VG, Peyton JD, West-Osterfield K, Clark BL, Vazquez ER, Jones SF, Burris HA, Greco FA.

J Thorac Oncol. 2010 Jun;5(6):862-6.

19.

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.

Hainsworth JD, Burris HA 3rd, Erland JB, Morrissey LH, Meluch AA, Kalman LA, Hon JK, Scullin DC Jr, Smith SW, Greco FA.

Cancer. 1999 Mar 15;85(6):1269-76.

PMID:
10189131
20.

UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.

Igishi T, Shigeoka Y, Yasuda K, Suyama H, Katayama S, Sugitani A, Matsumoto S, Yamamoto M, Ueda Y, Takeda K, Sumikawa T, Sako T, Kodani M, Hitsuda Y, Shimizu E.

J Thorac Oncol. 2009 Mar;4(3):376-82. doi: 10.1097/JTO.0b013e3181989dfc.

Supplemental Content

Support Center